Mashup Score: 3
JAMA NetworkThis cohort study uses a novel population-based methodology to estimate the proportion of older adult Medicare Fee-for-Service beneficiaries with cancer who participate in interventional cancer clinical trials.
See more from Catherine Marshall
Interventional clinical trial participation is really low!! 1%!! Even though we have more and more new standard of care therapies for patients, participation in clinical trials (which sometimes include these standard of care treatments) should still be considered with every treatment change.